Re-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19

Cited 67 time in webofscience Cited 43 time in scopus
  • Hit : 329
  • Download : 172
DC FieldValueLanguage
dc.contributor.authorPark, Jang Hyunko
dc.contributor.authorLee, Heung Kyuko
dc.date.accessioned2020-10-21T05:55:05Z-
dc.date.available2020-10-21T05:55:05Z-
dc.date.created2020-10-05-
dc.date.created2020-10-05-
dc.date.issued2020-08-
dc.identifier.citationFRONTIERS IN IMMUNOLOGY, v.11, pp.2145-
dc.identifier.issn1664-3224-
dc.identifier.urihttp://hdl.handle.net/10203/276809-
dc.description.abstractSARS-CoV-2 infection has recently been declared a pandemic. Some patients showing severe symptoms exhibit drastic inflammation and airway damage. In this study, we re-analyzed published scRNA-seq data of COVID-19 patient bronchoalveolar lavage fluid to further classify and compare immunological features according to the patient's disease severity. Patients with severe symptoms showed DNA damage and apoptotic features of epithelial cells. Our results suggested that epithelial damage was associated with neutrophil infiltration. Myeloid cells of severe patients showed higher expression of proinflammatory cytokines and chemokines such as CXCL8. As a result, neutrophils were abundant in lungs of patients from the severe group. Furthermore, recruited neutrophils highly expressed genes related to neutrophil extracellular traps. Neutrophil-mediated inflammation was regulated by glucocorticoid receptor expression and activity. Based on these results, we suggest that severe COVID-19 symptoms may be determined by differential expression of glucocorticoid receptors and neutrophils.-
dc.languageEnglish-
dc.publisherFRONTIERS MEDIA SA-
dc.titleRe-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19-
dc.typeArticle-
dc.identifier.wosid000570540100001-
dc.identifier.scopusid2-s2.0-85090786188-
dc.type.rimsART-
dc.citation.volume11-
dc.citation.beginningpage2145-
dc.citation.publicationnameFRONTIERS IN IMMUNOLOGY-
dc.identifier.doi10.3389/fimmu.2020.02145-
dc.contributor.localauthorLee, Heung Kyu-
dc.description.isOpenAccessY-
dc.type.journalArticleArticle-
dc.subject.keywordAuthorSARS-CoV-2-
dc.subject.keywordAuthorCOVID-19-
dc.subject.keywordAuthorneutrophil-
dc.subject.keywordAuthorCXCL8-
dc.subject.keywordAuthorglucocorticoid-
dc.subject.keywordAuthorBAL-
dc.subject.keywordAuthorscRNA-seq-
dc.subject.keywordPlusOBESITY-
dc.subject.keywordPlusINFLAMMATION-
dc.subject.keywordPlusEXPRESSION-
This item is cited by other documents in WoS
⊙ Detail Information in WoSⓡ Click to see webofscience_button
⊙ Cited 67 items in WoS Click to see citing articles in records_button

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0